Last Updated: May 6, 2026

Done - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Generic filers with tentative approvals for DONE
Applicant Application No. Strength Dosage Form
⤷  Start Trial⤷  Start Trial10MGTABLET; ORAL
⤷  Start Trial⤷  Start Trial5MGTABLET; ORAL
⤷  Start Trial⤷  Start Trial10MG;21MGCAPSULE, EXTENDED RELEASE;ORAL

The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.

US Patents and Regulatory Information for done

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xiamen Lp Pharm Co MEMANTINE HYDROCHLORIDE AND DONEPEZIL HYDROCHLORIDE donepezil hydrochloride; memantine hydrochloride CAPSULE, EXTENDED RELEASE;ORAL 216901-002 Jul 15, 2025 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Sun Pharm Industries DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 077975-001 Dec 11, 2009 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Aurobindo DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090056-001 May 31, 2011 AB RX No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Zydus Pharms Usa Inc DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 090175-001 May 10, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Natco Pharma DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090521-002 May 31, 2011 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Chartwell Rx DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET, ORALLY DISINTEGRATING;ORAL 078388-001 Nov 26, 2010 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
Osmotica Pharm Us DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 203114-001 Jan 26, 2016 DISCN No No ⤷  Start Trial ⤷  Start Trial ⤷  Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.